日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Navigating Immunotherapy Resistance: The Role of Cross-Line Strategies in Cancer Treatment

应对免疫疗法耐药性：交叉治疗策略在癌症治疗中的作用

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm15072751
Kang, Yan; Zhen, Hongchao; Wang, Jing; Lin, Haishan; Cao, Bangwei
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Inosine enhances the efficacy of immune-checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study

肌苷可增强免疫检查点抑制剂在晚期实体瘤中的疗效：一项随机、对照的 II 期研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70143
Zhao, Haiqing; Zhang, Wei; Lu, Yuting; Dong, Yin; He, Zhihao; Zhen, Hongchao; Li, Qin
免疫/内分泌
发表日期：2024
文献求助 收藏

Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets

基于多数据集鉴定直肠癌放射治疗敏感性相关的关键基因和潜在分子机制

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-023-04029-2
Zhao, Pengfei; Zhen, Hongchao; Zhao, Hong; Huang, Yongjie; Cao, Bangwei
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

雷替曲塞增强了安罗替尼对人食管鳞状细胞癌细胞增殖、侵袭和凋亡的抗肿瘤作用

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-10691-y
Zhen Hongchao, Tian Jizheng, Li Guangxin, Zhao Pengfei, Zhang Ying, Che Juanjuan, Cao Bangwei
肿瘤
Human
凋亡
发表日期：2023
文献求助 收藏

Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature

接受免疫检查点抑制剂和放射治疗的下咽癌患者发生脑炎：病例报告及文献综述

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05328-3
Kang, Yan; Zhen, Hongchao; Ma, Nina; Zhao, Hong; Cao, Bangwei
肿瘤
脑炎
肿瘤免疫
神经科学
免疫/内分泌
发表日期：2023
文献求助 收藏

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials

辅助性 EGFR-TKI 治疗切除术后非小细胞肺癌的疗效和安全性：基于随机对照试验的系统评价和荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09444-0
Zhao, Pengfei; Zhen, Hongchao; Zhao, Hong; Zhao, Lei; Cao, Bangwei
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis

免疫检查点抑制剂治疗患者发生心脏不良事件的风险：系统评价和荟萃分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.645245
Hu, Jiexuan; Tian, Ruyue; Ma, Yingjie; Zhen, Hongchao; Ma, Xiao; Su, Qiang; Cao, Bangwei
Checkpoint
免疫/内分泌
发表日期：2021
文献求助 收藏

Clinical observation of the efficacy of PD-1/PD-L1 inhibitors in the treatment of patients with advanced solid tumors

PD-1/PD-L1抑制剂治疗晚期实体瘤患者疗效的临床观察

期刊:Immunity Inflammation and Disease
影响因子:2.7
doi:10.1002/iid3.511
Wang, Miao; Zhen, Hongchao; Jiang, Xiaoyue; Lu, Yuting; Wei, Yuhan; Jin, Jiangtao; Li, Qin
PD-L1
PD-1
发表日期：2021
文献求助 收藏

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer

Dlg5表达降低与鳞状细胞肺癌预后不良和上皮-间质转化相关

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-21-752
Che, Juanjuan; Wang, Jing; Li, Huihui; Zhen, Hongchao; Shang, Kun; Yang, Yan; Cao, Bangwei
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

伊立替康双药联合治疗与伊立替康单药治疗作为晚期胃癌二线治疗方案的比较

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-018-0772-4
Yang, Liuting; Jiang, Xiaoyue; Yan, Han; Li, Yingying; Zhen, Hongchao; Chang, Bingmei; Kariminia, Seyed; Li, Qin
胃癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏